Decades of Poor Availability of Epinephrine Auto-Injectors – Global Problems in Need of Global Solutions
Guidelines recommend prompt use of intramuscular epinephrine as first-line treatment for anaphylaxis 1-5. Patients at-risk of anaphylaxis are generally couselled by medical professionals to carry epinephrine in the form of an epinephrine auto-injector (EAI) to treat a severe allergic reaction. Despite its critical role as a life-saving medication, availability of EAIs differs around the world. Shortages of EAIs have compounded this problem.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Susan Waserman, Ernie Avilla, Laurie Harada, Joni Huang, Monika Kastner Tags: Letters Source Type: research